Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE StudyHoward S. Höchster, Eric Hedrick, John D. Hainsworth et al.|Journal of Clinical Oncology|2008Cited by 623
Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC): Final analysis of the TREE-StudyH. S. Hochster, Barrett H. Childs, Lowell L. Hart et al.|Journal of Clinical Oncology|2006Cited by 137